Medidata Cloud Securely Manages Echocardiogram Images for Global Heart Measurement Study
October 10 2018 - 8:30AM
Business Wire
Study to benchmark heart dimension and function
based on diversity
News summary:
- Results of World Alliance of Societies
of Echocardiography (WASE) Normal Values Study will change standard
of care for cardiovascular paradigms
- Medidata Cloud unifies imaging data
across the study process, improving efficiency and
collaboration
- American Society of Echocardiography
Foundation and its affiliated international alliance partners,
MedStar, University of Chicago, and Medidata are collaborating on
the study, which recently reached 2,000 diverse subjects, spanning
18 countries across six continents
Medidata (NASDAQ:MDSO) today announced that Medidata Cloud, the
Intelligent Platform for Life Sciences, is streamlining the
management of medical images for the World Alliance of Societies of
Echocardiography (WASE) Normal Values Study. WASE is the first
study of its kind to measure heart dimension and function across
countries, geographical regions, cultures, gender, and age to
benchmark differences based on diversity.
The WASE study shares a high number of echocardiogram (echo)
files across continents and countries. Echo files are large and
require specialized and secure technology. The study leverages
Medidata Rave Imaging to:
- De-identify, acquire, transmit and
store all echo images from sites globally
- Simplify the management and sharing of
images among doctors participating in the study
“We know the importance of diversity in clinical trials, and
this study is a key factor in forwarding that goal and benchmarking
differences in heart size and function,” said Federico M. Asch, MD,
FASE, MedStar Health Research Institute in Washington, DC. “We look
forward to presenting the WASE data next year, and strongly believe
it will inform approaches based on diversity factors.”
Launched in June 2016, the WASE study is funded by the American
Society of Echocardiography (ASE) Foundation and supported by
Medidata, the MedStar Health Research Institute, University of
Chicago and TOMTEC Imaging Systems. Its purpose is to create a
global database of normal heart values to inform and potentially
change the standard of care for a broad range of cardiovascular
paradigms based on diversity criteria. To date, the study enrolled
more than 2,000 subjects in six continents and 18 countries.
“We’re proud our platform is powering this important study,
enabling global collaboration, and helping to achieve diversity in
clinical research,” said Glen de Vries, co-founder and president,
Medidata.
About WASE Study
The World Alliance of Societies of Echocardiography (WASE)
Normal Values Study was launched in 2016 and has centers in six
continents and 18 countries, including the Argentina, Australia,
Belgium, Brazil, Canada, China, France, India, Indonesia, Iran,
Italy, Japan, Korea, Mexico, Nigeria, Philippines, United Kingdom
and United States. The study is funded by the American Society of
Echocardiography (ASE) Foundation and sponsored by Medidata, the
MedStar Health Research Institute, University of Chicago and TOMTEC
Imaging Systems. To date, the study has reached over 2,000 enrolled
subjects and the final results will be shared in 2019.
About Medidata
Medidata is leading the digital transformation of life sciences,
with the world's most used platform for clinical development,
commercial, and real-world data. Powered by artificial intelligence
and delivered by the #1 ranked industry experts, the Intelligent
Platform for Life Sciences helps pharmaceutical, biotech, medical
device companies, and academic researchers accelerate value,
minimize risk and optimize outcomes. Medidata serves more than
1,000 customers and partners worldwide and empowers more than
100,000 certified users everyday to create hope for millions of
patients. Discover the future of life sciences: www.mdsol.com
About MedStar Health Research Institute
The MedStar Health Research Institute is the research arm of
MedStar Health, the largest healthcare provider in Maryland and the
Washington, D.C., region. MHRI provides scientific, administrative
and regulatory support for research programs throughout the MedStar
Health system. MHRI’s expertise includes translational research
into disease prevention, diagnosis and treatment. These programs
complement the key clinical services and teaching programs in the
10 MedStar hospitals and other MedStar entities. For more
information, visit www.MedStarResearch.org.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181010005151/en/
MedidataInvestors:Betsy Frank,
917-522-4620bfrank@mdsol.comorMedia:Erik Snider,
646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Sep 2023 to Sep 2024